Outcomes after thrombolysis in AIS according to prior statin use: A registry and review

Neurology

Volumn 79, Issue 17, 2012, Pages 1817-1823

  Meseguer, Elena ^a,b   Mazighi, Mikael ^a,b   Lapergue, Bertrand ^a,b   Labreuche, Julien ^b   Sirimarco, Bst Gaia ^a   Gonzalez Valcarcel, Jaime ^a   Lavallée, Philippa C ^a,b   Cabrejo, Lucie ^a,b   Guidoux, Céline ^a,b   Klein, Isabelle F ^a,b   Olivot, Jean Marc ^a   Rouchaud, Aymeric ^a,b   Desilles, Jean Philippe ^a,b   Amarenco, Pierre ^a,b  

^a BICHAT HOSPITAL   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; DISEASE REGISTRY; HUMAN; MEDLINE; PRIORITY JOURNAL; RECANALIZATION; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 84871257931     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318270400b     Document Type: Review

References (30)

1. Goldstein LB, Amarenco P, Zivin J, et al. Statin treatment and outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 2009;40:3526-3531.
2. Lakhan SE, Bagchi S, Hofer M. Statins and clinical outcome of acute ischemic stroke: a systematic review. Int Arch Med 2010;3:22.
3. Arboix A, García-Eroles L, Oliveres M, Targa C, Balcells M, Massons J. Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia BMC Neurol 2010;10:47.
4. Blanco M, Nombela F, Castellanos M, et al. Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology 2007;69:904-910.
5. Montaner J, Chacón P, Krupinski J, et al. Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial. Eur J Neurol 2008;15:82-90.
6. Sironi L, Cimino M, Guerrini U, et al. Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage. Arterioscler Thromb Vasc Biol 2003;23:322-327.
7. Kawashima S, Yamashita T, Miwa Y, et al. HMG-CoA reductase inhibitor has protective effects against stroke events in stroke-prone spontaneously hypertensive rats. Stroke 2003;34:157-163.
8. Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol 2009;8: 453-463.
9. Goldstein LB, Amarenco P, Szarek M, et al. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology 2008;70:2364-2370.
10. Engelter ST, Soinne L, Ringleb P, et al. IV thrombolysis and statins. Neurology 2011;77:888-895.
11. Martinez-Ramirez S, Delgado-Mederos R, Marín R, et al. Statin pretreatment may increase the risk of symptomatic intracranial haemorrhage in thrombolysis for ischemic stroke: results from a case-control study and a metaanalysis. J Neurol 2012;259:111-118.
12. Cappellari M, Deluca C, Tinazzi M, et al. Does statin in the acute phase of ischemic stroke improve outcome after intravenous thrombolysis? A retrospective study. J Neurol Sci 2011;308:128-134.
13. Faivre A, Sagui E, Canini F, et al. [Intravenous thrombolysis with rt-PA in stroke: experience of the French military hospital of Toulon from September 2003 to June 2009.] Rev Neurol 2010;166:909-920.
14. Miedema I, Uyttenboogaart M, Koopman K, De Keyser J, Luijckx GJ. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke. Cerebrovasc Dis 2010;29:263-267.
15. Georgiadis AL, Hussein HM, Vazquez G, et al. Premorbid use of statins is associated with higher recanalization rates in patients with acute ischemic stroke undergoing endovascular treatment. J Neuroimaging 2009;19:19-22.
16. Meier N, Nedeltchev K, Brekenfeld C, et al. Prior statin use, intracranial hemorrhage, and outcome after intraarterial thrombolysis for acute ischemic stroke. Stroke 2009;40:1729-1737.
17. Mazighi M, Serfaty JM, Labreuche J, et al. Comparison of intravenous alteplase with a combined intravenousendovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol 2009;8:802-809.
18. Meseguer E, Mazighi M, Labreuche J, et al. Outcomes of intravenous recombinant tissue plasminogen activator therapy according to gender: a clinical registry study and systematic review. Stroke 2009;40:2104-2110.
19. Rouchaud A, Mazighi M, Labreuche J, et al. Outcomes of mechanical endovascular therapy for acute ischemic stroke: a clinical registry study and systematic review. Stroke 2011;42:1289-1294.
20. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333: 1581-1587.
21. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings. N Engl J Med 1985;312:932-936.
22. Hacke W, Kaste M, Fieschi C, et al. Randomised doubleblind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998;352:1245-1251.
23. van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med 2002;21:589-624.
24. Montaner J. Cholesterol measured before stroke thrombolysis is not associated with tissue plasminogen activatorrelated hemorrhagic transformation. Stroke 2008;39:e6.
25. Restrepo L, Bang OY, Ovbiagele B, et al. Impact of hyperlipidemia and statins on ischemic stroke outcomes after intra-arterial fibrinolysis and percutaneous mechanical embolectomy. Cerebrovasc Dis 2009;28:384-390.
26. Makihara N, Okada Y, Koga M, et al. [Effects of statin use on intracranial hemorrhage and clinical outcome after intravenous rt-PA for acute ischemic stroke: SAMURAI rt-PA registry.] Rinsho Shinkeigaku 2010;50:225-231.
27. Bang OY, Saver JL, Liebeskind DS, et al. Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis. Neurology 2007;68:737-742.
28. Alvarez-Sabín J, Huertas R, Quintana M, et al. Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator. Stroke 2007;38:1076-1078.
29. Uyttenboogaart M, Koch MW, Koopman K, Vroomen PC, Luijckx GJ, De Keyser J. Lipid profile, statin use, and outcome after intravenous thrombolysis for acute ischaemic stroke. J Neurol 2008;255:875-880.
30. Dubas F. [Small vessel pathology and cerebral hemorrhage.] J Neuroradiol 2003;30:298-302.